American Parkinson Disease Association

American Parkinson Disease Association
Name	American Parkinson Disease Association
Formation	1961
Type	Nonprofit
Headquarters	New York City, New York
Region served	United States
Leader title	President

American Parkinson Disease Association is a US-based nonprofit organization focused on supporting people affected by Parkinson disease, funding scientific research, and providing education and advocacy. Founded in 1961, the organization connects patients, families, clinicians, researchers, and policymakers through a national network of chapters, resource centers, and outreach programs. Its activities intersect with clinical institutions, biomedical research centers, philanthropic foundations, and legislative efforts that shape Parkinson disease care and investigation.

History

The association was established in 1961 amid growing attention to neurological disorders that followed advances at institutions such as Columbia University, Johns Hopkins Hospital, Mayo Clinic, Mount Sinai Hospital (Manhattan), and Massachusetts General Hospital. Early leadership included clinicians and advocates who collaborated with laboratories at National Institutes of Health, Rockefeller University, and medical schools like University of Pennsylvania School of Medicine and University of California, San Francisco School of Medicine. Over subsequent decades, the organization expanded through partnerships with foundations such as the Michael J. Fox Foundation for Parkinson's Research, the Gates Foundation, and the Robert Wood Johnson Foundation, while engaging with patient advocacy movements similar to those around March of Dimes and Alzheimer's Association. The association’s growth paralleled major scientific milestones at centers like Stanford University School of Medicine and companies such as AbbVie and Biogen that later developed therapeutics targeting Parkinson-related pathways.

Mission and Programs

The association’s mission emphasizes support for people living with Parkinson disease, education for caregivers and clinicians, and promotion of research into causes, treatments, and improved quality of life. Programmatic offerings resemble services provided by organizations such as American Heart Association, American Cancer Society, and Juvenile Diabetes Research Foundation in providing helplines, support groups, and educational symposia. Key programs include telehealth resources that align with initiatives at Cleveland Clinic and Mount Sinai Health System, exercise and rehabilitation referrals similar to those promoted by American Physical Therapy Association, and caregiver support modeled on practices used by Alzheimer's Association and AARP. Collaborative efforts often involve clinical trial matching with sites at University of Michigan Health System, Duke University School of Medicine, and Columbia University Irving Medical Center.

Research and Funding

The association funds basic, translational, and clinical research, awarding grants to investigators at universities like Harvard Medical School, University of Pennsylvania, Yale School of Medicine, and University of California, Los Angeles School of Medicine. It has co-funded consortia and investigator-initiated projects alongside entities such as National Institute of Neurological Disorders and Stroke, Michael J. Fox Foundation for Parkinson's Research, and pharmaceutical partners including Roche and Merck. Research priorities span neurodegeneration studies connected to work at Salk Institute for Biological Studies, genetic investigations akin to studies at Broad Institute, biomarker development paralleling initiatives at Fred Hutchinson Cancer Research Center, and therapeutic pipelines informed by research at Novartis and GlaxoSmithKline. Grant programs often support early-career scientists affiliated with programs at Massachusetts Institute of Technology, California Institute of Technology, and Johns Hopkins University. The association also organizes research symposia resembling conferences held by American Academy of Neurology and Society for Neuroscience.

Education and Outreach

Educational initiatives include printed and digital resources, webinars, and community workshops modeled after continuing education programs at Cleveland Clinic Lerner College of Medicine and Mayo Clinic Proceedings. Outreach targets clinicians, caregivers, and people with Parkinson disease through collaborations with academic centers like University of California, San Diego, specialty clinics patterned on those at Mount Sinai Beth Israel, and allied health organizations such as American Speech-Language-Hearing Association. Public awareness campaigns draw on strategies used by National Multiple Sclerosis Society and Susan G. Komen, leveraging media partnerships with broadcasters and publishers comparable to National Public Radio, The New York Times, and CNN. Educational materials reference standards and guidelines from bodies like American Academy of Neurology and coordinate with registries employed by Parkinson's Progression Markers Initiative participants.

Chapters and Volunteer Network

A nationwide chapter structure mirrors models used by American Red Cross, Habitat for Humanity, and YMCA of the USA, connecting local volunteers, support groups, and resource centers. Chapters collaborate with regional hospitals such as NYU Langone Health, Rush University Medical Center, and University of Texas Southwestern Medical Center to host exercise programs, caregiver trainings, and multidisciplinary clinics. Volunteer roles include helpline responders, event coordinators, and peer mentors similar to volunteer models at Meals on Wheels America and Alzheimer's Association chapters. The association’s volunteer network also partners with academic clinical trials sites at Northwestern Memorial Hospital and community rehabilitation providers modeled on Goodwill Industries workforce programs.

Advocacy and Public Policy

Advocacy work targets legislative and regulatory frameworks affecting Parkinson disease care, drawing on coalitions that include organizations such as Paralyzed Veterans of America, National Multiple Sclerosis Society, and American Kidney Fund. Policy priorities include research funding at agencies like National Institutes of Health, Medicare and Medicaid coverage issues relating to services at Centers for Medicare & Medicaid Services, and access to therapies regulated by Food and Drug Administration. The association engages with members of Congress, state health departments, and coalitions similar to those assembled by Patient-Centered Outcomes Research Institute to influence funding, clinical trial access, and disability policy. Public policy efforts also coordinate with international partners including groups at World Health Organization and patient organizations allied with the European Parkinson's Disease Association.

Category:Medical and health organizations in the United States